We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002460:SZSEHS Hwasung Co., Ltd. Analysis

Data as of 2026-03-14 - not real-time

₩12,830.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

HS Hwasung is trading at 12,830 KRW, comfortably above its 50‑day (12,520) and 200‑day (11,337) SMAs but slightly below the 20‑day SMA (13,370), signaling a short‑term pull‑back within a longer‑term bullish backdrop. The market shows a bullish trend direction and increasing volume, yet the MACD is in bearish territory and the RSI sits near the neutral 48.7, suggesting caution ahead of the next move toward the 15,780 resistance. Volatility is elevated at over 52% on a 30‑day basis, but a very low computed beta (0.15) points to limited systematic risk, while the dividend yield of 5.85% with a modest 14% payout ratio underscores cash‑flow strength. Fundamentally, the company posted a 21.6% revenue growth year‑over‑year, maintains modest margins (gross 13.5%, operating 11.4%, profit 4.7%), and holds a near‑cash‑neutral balance sheet (cash 183B KRW vs debt 193B KRW). The price‑to‑sales ratio of 0.17 and a DCF‑derived fair value far above the current price indicate a significant undervaluation, while the strong dividend and low debt‑to‑equity (≈47%) enhance the case for a sustainable, income‑focused investment.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support with room to absorb short‑term volatility
  • Bearish MACD and neutral RSI signal caution
  • Increasing volume supports a stable near‑term outlook

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to sales and DCF fair value
  • High dividend yield with low payout ratio
  • Revenue growth and improving cash position

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained infrastructure demand in South Korea
  • Low systematic risk (beta) and stable earnings base
  • Attractive dividend sustainability and capital appreciation upside

Key Metrics & Analysis

Financial Health

Revenue Growth121.60%
Profit Margin4.65%
ROE9.48%
ROA3.33%
Debt/Equity46.97
Op. Cash Flow₩127.6B
Free Cash Flow₩133.7B
Industry P/E29.1

Technical Analysis

TrendBullish
RSI48.7
Support₩11,860.00
Resistance₩15,780.00
MA 20₩13,370.00
MA 50₩12,519.80
MA 200₩11,336.55
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair Value₩525,455.86
GradeUndervalued
TypeBlend
Dividend Yield5.85%

Risk Assessment

Beta0.15
Volatility52.86%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.